These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 33074771)

  • 21. Renal denervation: current implications and future perspectives.
    Xu J; Hering D; Sata Y; Walton A; Krum H; Esler MD; Schlaich MP
    Clin Sci (Lond); 2014 Jan; 126(1):41-53. PubMed ID: 24020446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the renal afferent and efferent nerve fibers in heart failure.
    Booth LC; May CN; Yao ST
    Front Physiol; 2015; 6():270. PubMed ID: 26483699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure.
    Böhm M; Ewen S; Linz D; Reil JC; Schirmer SH; Ukena C; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R122-6. PubMed ID: 23732144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal sympathetic denervation: applications in hypertension and beyond.
    Böhm M; Linz D; Urban D; Mahfoud F; Ukena C
    Nat Rev Cardiol; 2013 Aug; 10(8):465-76. PubMed ID: 23774592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of sympathetic nervous system in the progression of chronic kidney disease in the era of catheter based sympathetic renal denervation.
    Petras D; Koutroutsos K; Kordalis A; Tsioufis C; Stefanadis C
    Curr Clin Pharmacol; 2013 Aug; 8(3):197-205. PubMed ID: 23173962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of catheter-based renal denervation on heart failure with reduced ejection fraction: a systematic review and meta-analysis.
    Fukuta H; Goto T; Wakami K; Ohte N
    Heart Fail Rev; 2017 Nov; 22(6):657-664. PubMed ID: 28646466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal Denervation in Heart Failure.
    Fong MW; Shavelle D; Weaver FA; Nadim MK
    Curr Hypertens Rep; 2015 Mar; 17(3):17. PubMed ID: 25754320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
    Kiuchi MG; Nolde JM; Villacorta H; Carnagarin R; Chan JJS; Lugo-Gavidia LM; Ho JK; Matthews VB; Dwivedi G; Schlaich MP
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal denervation in male rats with heart failure improves ventricular sympathetic nerve innervation and function.
    Pinkham MI; Loftus MT; Amirapu S; Guild SJ; Quill G; Woodward WR; Habecker BA; Barrett CJ
    Am J Physiol Regul Integr Comp Physiol; 2017 Mar; 312(3):R368-R379. PubMed ID: 28052866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?
    Böhm M; Linz D; Ukena C; Esler M; Mahfoud F
    Circ Res; 2014 Jul; 115(3):400-9. PubMed ID: 25035133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal and cardiac effects of renal sympathetic denervation and carotid baroreceptor stimulation.
    Tsioufis C; Dimitriadis K; Thomopoulos C; Doumas M; Papademetriou V; Stefanadis C
    Curr Vasc Pharmacol; 2014 Jan; 12(1):55-62. PubMed ID: 23905593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New treatment for old disease: management of resistant hypertension by percutaneous renal sympathetic denervation.
    Kanai T; Krum H
    Rev Esp Cardiol (Engl Ed); 2013 Sep; 66(9):734-40. PubMed ID: 24773680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal sympathetic denervation for treating resistant hypertension.
    Polimeni A; Curcio A; Indolfi C
    Circ J; 2013; 77(4):857-63. PubMed ID: 23514712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary effects of renal denervation with saline irrigated catheter on cardiac systolic function in patients with heart failure: A Prospective, Randomized, Controlled, Pilot Study.
    Chen W; Ling Z; Xu Y; Liu Z; Su L; Du H; Xiao P; Lan X; Shan Q; Yin Y
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E153-E161. PubMed ID: 27143319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal Afferents.
    Frame AA; Carmichael CY; Wainford RD
    Curr Hypertens Rep; 2016 Sep; 18(9):69. PubMed ID: 27595156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Renal denervation: current state and future perspectives].
    Kara K; Bruck H; Kahlert P; Plicht B; Mahabadi AA; Konorza T; Erbel R
    Herz; 2012 Nov; 37(7):746-53. PubMed ID: 23073661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal sympathetic denervation alleviates myocardial fibrosis following isoproterenol-induced heart failure.
    Wang N; Zheng X; Qian J; Yao W; Bai L; Hou G; Qiu X; Li X; Jiang X
    Mol Med Rep; 2017 Oct; 16(4):5091-5098. PubMed ID: 28849013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ablating the renal nerves to treat heart failure with reduced ejection fraction: another treatment option in a crowded space?
    Esler M
    Clin Auton Res; 2020 Dec; 30(6):499-500. PubMed ID: 33175274
    [No Abstract]   [Full Text] [Related]  

  • 39. Deep and future insights into neuromodulation therapies for heart failure.
    Kishi T
    J Cardiol; 2016 Nov; 68(5):368-372. PubMed ID: 27293020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?
    Tsioufis C; Iliakis P; Kasiakogias A; Konstantinidis D; Lovic D; Petras D; Doumas M; Tsiamis E; Papademetriou V; Tousoulis D
    Curr Vasc Pharmacol; 2017; 16(1):30-43. PubMed ID: 28462724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.